XML 112 R87.htm IDEA: XBRL DOCUMENT v3.23.1
Note 5 - Balance Sheet Components - Summary of Accrued Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Accrued clinical trial and manufacturing costs $ 4,201 $ 4,340 $ 6,472
Accrued personnel costs 494 497 1,172
Other accrued liabilities 799 522 844
Total accrued liabilities $ 5,494 $ 5,359 $ 8,488